Research Article
Alterations in Rapid Eye Movement Sleep Parameters Predict for Subsequent Progression from Mild Cognitive Impairment to Alzheimers Disease
Hideto Shinno1*, Ichiro Ishikawa2, Nobuo Ando2, Yoshihito Matsumura1, Jun Horiguchi3 and Yu Nakamura2
1Department of Liaison Psychiatry, Kagawa University School of Medicine, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan
2Department of Neuropsychiatry, Kagawa University School of Medicine, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan
3Department of Psychiatry, Shimane University Faculty of Medicine, 85-1 Enya, Izumo, Shimane 693-8501, Japan
- Corresponding Author:
- Hideto Shinno
Professor, Department of Liaison Psychiatry
Kagawa University School of Medicine
1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan
Tel: +81-87-891-2165
E-mail: shinnoh@med.kagawa-u.ac.jp
Received date: February 24, 2016; Accepted date: March 04, 2016; Published date: March 11, 2016
Citation: Shinno H, Ishikawa I, Ando N, Matsumura Y, Horiguchi J, et al. (2016) Alterations in Rapid Eye Movement Sleep Parameters Predict for Subsequent Progression from Mild Cognitive Impairment to Alzheimer’s Disease. J Alzheimers Dis Parkinsonism 6:218. doi:10.4172/2161-0460.1000218
Copyright: © 2016 Shinno H, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Objective: Mild cognitive impairment (MCI) refers to the clinical condition between normal aging and Alzheimer’s disease (AD). Heterogeneity in this entity has also been recognized, and an accelerated rate of progression to AD was documented in some individuals diagnosed with MCI. It is important for the early detection of and intervention for AD to determine the clinical subtype of MCI with a high risk of progression to AD. Studies have demonstrated that deceased glucose metabolism or regional cerebral blood flow in the posterior cingulate may be associated with a higher risk of such progression. The aim of this study was to investigate whether any polysomnography (PSG) variables support the prediction of progression from MCI to AD.
Methods: Twenty-four subjects with MCI were enrolled in this study. Clinical evaluation, cognitive screening tests, and PSG were carried out at the baseline. A diagnosis of MCI was made with standard criteria. Outcome measures were carried out to examine whether: 1) there was a significant cognitive decline, and 2) it progressed to AD according to the standard criteria for it. After a 2-year follow-up, subjects were divided into 2 groups. The MCI-AD group included subjects who progressed to AD, and the MCI-MCI group included those who did not meet the criteria for dementia. Basal PSG variables were compared between the groups.
Results: Nineteen subjects completed the study. Six subjects (32%) progressed to AD within 2 years. Subjects in the MCI-AD group showed a shorter stage REM sleep (p=0.043), and a reduced REM density (p=0.043) at the baseline.
Conclusion: Subjects who progressed to AD demonstrated altered REM sleep variables, yet they did not meet the criteria for clinically probable AD in the examination period. We consider that these properties may be associated with a higher risk of progression from MCI to AD.